Concepedia

Hayden M. Pagendarm

HM

4

Publications

169

Citations

4

H-Index

2020

Active since

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

VA Tennessee Valley Healthcare System

Vanderbilt Health

Hayden M. Pagendarm is an author at Vanderbilt University Medical Center specializing in medicine, gene delivery, and nanomedicine.

ORCID

Top concepts

Publications per year

2020–2025

4

Publications

4

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists

Jessalyn J. Baljon, Alexander J. Kwiatkowski, Hayden M. Pagendarm et al. · ACS Nano · 2024 · 87 citations · Full text

A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA

Carcia S. Carson, Kyle W. Becker, Kyle M. Garland et al. · Journal of Controlled Release · 2022 · 33 citations · Full text

, , +12

Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody–STING agonist conjugates

Blaise R. Kimmel, Karan Arora, Neil C. Chada et al. · Nature Biomedical Engineering · 2025 · 29 citations · Full text

Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists

Dinh Chuong Nguyen, Daniel Shae, Hayden M. Pagendarm et al. · Advanced Healthcare Materials · 2020 · 20 citations · Full text

, , +18

Rows per page

1–4 of 4